Sixty degrees pharmaceuticals and tufts medical center announce patent license agreement to advance development of tafenoquine for babesiosis treatment and prevention

60 degrees pharma and tufts mc partner to develop tafenoquine for babesiosis, co-own patents, and aim for fda approval to address unmet medical needs.

SXTP Ratings Summary

SXTP Quant Ranking